Journal of the American Society of Cytopathology

JASC is the official journal of the American Society of Cytopathology,and reflects the values and priorities of the society. JASC publishes regular bimonthly issues with cutting-edge original research of the highest standard. The Journal seeks to provide an exceptional forum for interaction and dissemination of original research and educational information in the field of cytopathology and other allied disciplines in medicine. The cross-disciplinary focus of the journal ensures the sharing of information with all readers involved in the practice of cytopathology and its related basic sciences, epidemiology and clinical oncologic disciplines.

JASC endeavors to have a positive impact not only on all aspects of cancer diagnosis and treatment, but also on other human disease. JASC publishes original work emphasizing novel discoveries or clinicopathologic correlations in a patient-centered environment, technological advances in basic and translational research with emphasis on the development of personalized medicine, and new or improved molecular techniques and their novel application for diagnosis or monitoring of disease. Preference is also given to original work demonstrating the scholarship of education in cytopathology including new innovative tools for continuing education and training as well as designing and implementing new assessment and evaluation techniques. It duly addresses and highlights issues relating to population health and public policy topics. It is the goal of JASC to lead the discipline of cytopathology by setting professional quality standards ensuring diagnostic excellence, advocating laboratory safety and quality, and inter-professional education for pathologists, cytotechnologists and all allied health care specialties.